JYMLEEP
associated with 14 other trademarks
Pharmaceutical and biological preparations for treating tenosynovial giant cell tumor (TGCT), giant cell tumor of the tendon sheath (GCT-TS), and pigm...

Words that describe this trademark:

Serial Number:

98322370

Mark:

JYMLEEP

Status:

Suspension letter-Mailed

Status Date:

11-08-2024

Filing Date:

Registration Number:

N/A

Registration Date:

N/A

Goods and Services:

Pharmaceutical and biological preparations for treating tenosynovial giant cell tumor (TGCT), giant cell tumor of the tendon sheath (GCT-TS), and pigmented villonodular synovitis (PVNS); Pharmaceutical and biological preparations for use in orthopedics, rheumatology, oncology, neurology, immunology, and hematology; Pharmaceutical and biological preparations for preventing, diagnosing, treating and managing diseases, disorders, and conditions affecting the musculoskeletal system, central nervous system, immune system, and blood; Pharmaceutical and biological preparations for treating tumors, sarcomas, tenosynovial giant cell tumors, graft versus host disease (GVHD), Parkinson's disease, Alzheimer's disease, and Amyotrophic Lateral Sclerosis (ALS); Therapeutic agents, namely, kinase inhibitors

Mark Description:

N/A

Class:

Pharmaceutical and veterinary preparations

Type of Mark:

Trademark

Published for Opposition Date:

N/A

Mark Drawing Status:

4

Abandon Date:

N/A

Business Name:

ONE FINANCIAL CENTER

Recent Trademark filings by this company